ODYS vs VRTX · rev $502.0K vs P/E 30, rev $3.33B
Odysight.ai Inc. Common Stock (ODYS) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Odysight.ai Inc. Common Stock (ODYS) is a scientific & technical instruments company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported ODYS revenue for 2026-06-30 was $502.0K. Net income was -$9.5M. ODYS currently screens at market cap $69.1M.
Latest reported VRTX revenue for 2026-06-30 was $3.33B. Net income was $1.10B. Revenue was up 11.6% from 2026-03-31 to 2026-06-30. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
ODYS currently screens at market cap $69.1M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the ODYS and VRTX stock pages for the full models.
Not investment advice.